Before this discussion, if I had had a good vaccine candidate, I would have taken it to a GLP/GMP facility and asked them to produce a lot suitable for conducting clinical trials. I would then have gone to the CIHR Canadian HIV trials network with a proposal and had them vet the proposal and, with public funding for operational costs of the clinical trial, execute the clinical trial. That's what I would have done.
On April 13th, 2010. See this statement in context.